Q30 INNOVATIONS: Requests FDA Authorization for Q-Collar Device Designed to Aid in the Protection of the Brain from the Effects of Head Impacts in Contact Sports

After eight years of scientific research and clinical trials, Q30 Innovations announced that it has submitted a request for De Novo classification to the U.S. Food and Drug Administration, seeking authorization to market the Q-Collar in the United States.